Elizabeth Phillips
Last active: 3/30/2020

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. SJS/TEN 2019: From science to translation. Chang WC, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Beachkofsky TM, Bellón T, Biala AK, Bouchard C, Cavalleri GL, Chapman N, Chodosh J, Choi HK, Cibotti RR, Divito SJ, Dewar K, Dehaeck U, Etminan M, Forbes D, Fuchs E, Goldman JL, Holmes JH, Hope EA, Hung SI, Hsieh CL, Iovieno A, Jagdeo J, Kim MK, Koelle DM, Lacouture ME, Le Pallec S, Lehloenya RJ, Lim R, Lowe A, McCawley J, McCawley J, Micheletti RG, Mockenhaupt M, Niemeyer K, Norcross MA, Oboh D, Olteanu C, Pasieka HB, Peter J, Pirmohamed M, Rieder M, Saeed HN, Shear NH, Shieh C, Straus S, Sukasem C, Sung C, Trubiano JA, Tsou SY, Ueta M, Volpi S, Wan C, Wang H, Wang ZQ, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung WH, Phillips EJ, Carleton BC (2020) J Dermatol Sci 98(1): 2-12
    › Primary publication · 32192826 (PubMed) · PMC7261636 (PubMed Central)
  2. Development and Validation of a Penicillin Allergy Clinical Decision Rule. Trubiano JA, Vogrin S, Chua KYL, Bourke J, Yun J, Douglas A, Stone CA, Yu R, Groenendijk L, Holmes NE, Phillips EJ (2020) JAMA Intern Med
    › Primary publication · 32176248 (PubMed) · PMC7076536 (PubMed Central)
  3. New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals. Pavlos R, Deshpande P, Chopra A, Leary S, Strautins K, Nolan D, Thorborn D, Shaefer M, Rauch A, Dunn D, Montaner J, Rachlis A, Almeida CA, Choo L, James I, Redwood AJ, Li Y, Gaudieri S, Mallal SA, Phillips EJ (2020) Hum Immunol 81(6): 300-304
    › Primary publication · 32173028 (PubMed) · PMC7266722 (PubMed Central)
  4. Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU. Stone CA, Stollings JL, Lindsell CJ, Dear ML, Buie RB, Rice TW, Phillips EJ (2020) Am J Respir Crit Care Med 201(12): 1572-1575
    › Primary publication · 32083961 (PubMed) · PMC7301733 (PubMed Central)
  5. Anaphylaxis to PEGylated liposomal echocardiogram contrast in a patient with IgE-mediated macrogol allergy. Krantz MS, Liu Y, Phillips EJ, Stone CA (2020) J Allergy Clin Immunol Pract 8(4): 1416-1419.e3
    › Primary publication · 31954852 (PubMed) · PMC7263401 (PubMed Central)
  6. Analysis of Skin-Resident Memory T Cells Following Drug Hypersensitivity Reactions. Trubiano JA, Gordon CL, Castellucci C, Christo SN, Park SL, Mouhtouris E, Konvinse K, Rose M, Goh M, Boyd AS, Phillips EJ, Mackay LK (2020) J Invest Dermatol 140(7): 1442-1445.e4
    › Primary publication · 31883960 (PubMed) · PMC7369252 (PubMed Central)
  7. Tolerance of porcine pancreatic enzymes despite positive skin testing in alpha-gal allergy. Stone CA, Choudhary S, Patterson MF, Rukasin CRF, Coleman DT, Phillips EJ, Commins SP (2020) J Allergy Clin Immunol Pract 8(5): 1728-1732.e1
    › Primary publication · 31846796 (PubMed) · PMC7217730 (PubMed Central)
  8. Penicillin Allergy. Castells M, Khan DA, Phillips EJ (2019) N Engl J Med 381(24): 2338-2351
    › Primary publication · 31826341 (PubMed)
  9. Highlights from the 2nd Biennial Stevens Johnson syndrome symposium 2019: SJS/TEN from Science to Translation. Saeed HN, Bouchard C, Shieh C, Phillips E, Chodosh J (2020) Ocul Surf 18(3): 483-486
    › Primary publication · 31785388 (PubMed) · PMC7307450 (PubMed Central)
  10. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms. Trubiano JA, Ostrov DA, Phillips EJ (2019) J Allergy Clin Immunol Pract 7(8): 2854-2856
    › Primary publication · 31706497 (PubMed) · PMC7255914 (PubMed Central)
  11. Safety of cephalosporins in penicillin class severe delayed hypersensitivity reactions. Trubiano JA, Chua KYL, Holmes NE, Douglas AP, Mouhtouris E, Goh M, Phillips EJ (2020) J Allergy Clin Immunol Pract 8(3): 1142-1146.e4
    › Primary publication · 31678298 (PubMed) · PMC7064395 (PubMed Central)
  12. Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit. Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Visotcky A, Fraser R, Pezzin L, Brousseau DC (2020) J Allergy Clin Immunol Pract 8(3): 1126-1128.e1
    › Primary publication · 31586667 (PubMed) · PMC7332348 (PubMed Central)
  13. Single-cell transcriptomics reveal polyclonal memory T-cell responses in skin with positive abacavir patch test results. Redwood AJ, Rwandamuriye F, Chopra A, Leary S, Ram R, McDonnell W, Konvinse K, White K, Pavlos R, Koelle DM, Mallal S, Phillips EJ (2019) J Allergy Clin Immunol 144(5): 1413-1416.e7
    › Primary publication · 31574267 (PubMed) · PMC7051072 (PubMed Central)
  14. Cephalosporin Allergy: Current Understanding and Future Challenges. Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, Ein D, Lang DM, Phillips E (2019) J Allergy Clin Immunol Pract 7(7): 2105-2114
    › Primary publication · 31495420 (PubMed) · PMC6955146 (PubMed Central)
  15. Immune-mediated adverse reactions to vaccines. Stone CA, Rukasin CRF, Beachkofsky TM, Phillips EJ (2019) Br J Clin Pharmacol 85(12): 2694-2706
    › Primary publication · 31472022 (PubMed) · PMC6955412 (PubMed Central)
  16. Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Pan RY, Chu MT, Wang CW, Lee YS, Lemonnier F, Michels AW, Schutte R, Ostrov DA, Chen CB, Phillips EJ, Mallal SA, Mockenhaupt M, Bellón T, Tassaneeyakul W, White KD, Roujeau JC, Chung WH, Hung SI (2019) Nat Commun 10(1): 3569
    › Primary publication · 31395875 (PubMed) · PMC6687717 (PubMed Central)
  17. Implications of electronic health record transition on drug allergy labels. Rukasin CRF, Henderlight S, Bosen T, Nelson SD, Phillips EJ (2020) J Allergy Clin Immunol Pract 8(2): 764-766
    › Primary publication · 31351188 (PubMed) · PMC6981006 (PubMed Central)
  18. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses. Grifoni A, Moore E, Voic H, Sidney J, Phillips E, Jadi R, Mallal S, De Silva AD, De Silva AM, Peters B, Weiskopf D, Sette A (2019) Front Immunol : 1568
    › Primary publication · 31333679 (PubMed) · PMC6624677 (PubMed Central)
  19. Oral challenge with trimethoprim-sulfamethoxazole in patients with "sulfa" antibiotic allergy. Krantz MS, Stone CA, Abreo A, Phillips EJ (2020) J Allergy Clin Immunol Pract 8(2): 757-760.e4
    › Primary publication · 31319222 (PubMed) · PMC6960372 (PubMed Central)
  20. Reply. Trubiano JA, Devchand M, Phillips EJ (2019) J Allergy Clin Immunol Pract 7(6): 2095-2096
    › Primary publication · 31279472 (PubMed)
  21. High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing. Meher-Homji Z, Tam CS, Siderov J, Seymour JF, Holmes NE, Chua KYL, Phillips EJ, Slavin MA, Trubiano JA (2019) Leuk Lymphoma 60(14): 3455-3460
    › Primary publication · 31256738 (PubMed) · PMC6928424 (PubMed Central)
  22. Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts. Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ (2019) J Allergy Clin Immunol Pract 7(7): 2151-2153
    › Primary publication · 31253580 (PubMed) · PMC6733665 (PubMed Central)
  23. Novel HLA Class I Alleles Outside the Extended DR3 Haplotype Are Protective against Autoimmune Hepatitis. Lammert C, McKinnon EJ, Chalasani N, Phillips EJ (2019) Clin Transl Gastroenterol 10(6): e00032
    › Primary publication · 31211758 (PubMed) · PMC6613860 (PubMed Central)
  24. High and variable population prevalence of HLA-B*56:02 in indigenous Australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms. Somogyi AA, Barratt DT, Phillips EJ, Moore K, Ilyas F, Gabb GM (2019) Br J Clin Pharmacol 85(9): 2163-2169
    › Primary publication · 31206740 (PubMed) · PMC6710506 (PubMed Central)
  25. Slow graded reintroduction of oxcarbazepine for delayed maculopapular eruption. Rukasin CRF, Phillips EJ, Norton AE (2019) Ann Allergy Asthma Immunol 123(4): 411-412
    › Primary publication · 31201862 (PubMed) · PMC6778716 (PubMed Central)
  26. A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms. Rwandamuriye FX, Chopra A, Konvinse KC, Choo L, Trubiano JA, Shaffer CM, Watson M, Mallal SA, Phillips EJ (2019) J Mol Diagn 21(5): 782-789
    › Primary publication · 31158526 (PubMed) · PMC6734857 (PubMed Central)
  27. Widespread Tau-Specific CD4 T Cell Reactivity in the General Population. Lindestam Arlehamn CS, Pham J, Alcalay RN, Frazier A, Shorr E, Carpenter C, Sidney J, Dhanwani R, Agin-Liebes J, Garretti F, Amara AW, Standaert DG, Phillips EJ, Mallal SA, Peters B, Sulzer D, Sette A (2019) J Immunol 203(1): 84-92
    › Primary publication · 31085590 (PubMed) · PMC6581570 (PubMed Central)
  28. Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions. Nicoletti P, Barrett S, McEvoy L, Daly AK, Aithal G, Lucena MI, Andrade RJ, Wadelius M, Hallberg P, Stephens C, Bjornsson ES, Friedmann P, Kainu K, Laitinen T, Marson A, Molokhia M, Phillips E, Pichler W, Romano A, Shear N, Sills G, Tanno LK, Swale A, Floratos A, Shen Y, Nelson MR, Watkins PB, Daly MJ, Morris AP, Alfirevic A, Pirmohamed M (2019) Clin Pharmacol Ther 106(5): 1028-1036
    › Primary publication · 31066027 (PubMed) · PMC7156285 (PubMed Central)
  29. The challenge of de-labeling penicillin allergy. Stone CA, Trubiano J, Coleman DT, Rukasin CRF, Phillips EJ (2020) Allergy 75(2): 273-288
    › Primary publication · 31049971 (PubMed) · PMC6824919 (PubMed Central)
  30. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. Konvinse KC, Trubiano JA, Pavlos R, James I, Shaffer CM, Bejan CA, Schutte RJ, Ostrov DA, Pilkinton MA, Rosenbach M, Zwerner JP, Williams KB, Bourke J, Martinez P, Rwandamuriye F, Chopra A, Watson M, Redwood AJ, White KD, Mallal SA, Phillips EJ (2019) J Allergy Clin Immunol 144(1): 183-192
    › Primary publication · 30776417 (PubMed) · PMC6612297 (PubMed Central)
  31. Prevention and Diagnosis of Severe T-Cell-Mediated Adverse Drug Reactions: Are We There Yet? Redwood A, Trubiano J, Phillips EJ (2019) J Allergy Clin Immunol Pract 7(1): 228-230
    › Primary publication · 30598178 (PubMed) · PMC6440535 (PubMed Central)
  32. Controversies in drug allergy: Testing for delayed reactions. Phillips EJ, Bigliardi P, Bircher AJ, Broyles A, Chang YS, Chung WH, Lehloenya R, Mockenhaupt M, Peter J, Pirmohamed M, Roujeau JC, Shear NH, Tanno LK, Trubiano J, Valluzzi R, Barbaud A (2019) J Allergy Clin Immunol 143(1): 66-73
    › Primary publication · 30573342 (PubMed) · PMC6429556 (PubMed Central)
  33. Antibiotic allergy. Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ (2019) Lancet 393(10167): 183-198
    › Primary publication · 30558872 (PubMed) · PMC6563335 (PubMed Central)
  34. Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. Stone CA, Liu Y, Relling MV, Krantz MS, Pratt AL, Abreo A, Hemler JA, Phillips EJ (2019) J Allergy Clin Immunol Pract 7(5): 1533-1540.e8
    › Primary publication · 30557713 (PubMed) · PMC6706272 (PubMed Central)
  35. The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study. Trubiano JA, Smibert O, Douglas A, Devchand M, Lambros B, Holmes NE, Chua KY, Phillips EJ, Slavin MA (2018) Open Forum Infect Dis 5(12): ofy306
    › Primary publication · 30547046 (PubMed) · PMC6287673 (PubMed Central)
  36. Precision HIV care: responding to old questions and meeting new challenges. Hulgan T, Dash C, Haas DW, Phillips EJ (2018) Pharmacogenomics 19(17): 1299-1302
    › Primary publication · 30325267 (PubMed)
  37. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USA. Moore E, Grifoni A, Weiskopf D, Schulten V, Arlehamn CSL, Angelo M, Pham J, Leary S, Sidney J, Broide D, Frazier A, Phillips E, Mallal S, Mack SJ, Sette A (2018) Hum Immunol 79(12): 821-822
    › Primary publication · 30278218 (PubMed) · PMC6537871 (PubMed Central)
  38. The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts. Trubiano JA, Douglas AP, Goh M, Slavin MA, Phillips EJ (2019) J Allergy Clin Immunol Pract 7(4): 1341-1343.e1
    › Primary publication · 30266590 (PubMed) · PMC6435428 (PubMed Central)
  39. Pathways to improved antibiotic allergy and antimicrobial stewardship practice: The validation of a beta-lactam antibiotic allergy assessment tool. Devchand M, Urbancic KF, Khumra S, Douglas AP, Smibert O, Cohen E, Sutherland M, Phillips EJ, Trubiano JA (2019) J Allergy Clin Immunol Pract 7(3): 1063-1065.e5
    › Primary publication · 30172019 (PubMed) · PMC6395557 (PubMed Central)
  40. NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS. Phillips EJ (2018) Trans Am Clin Climatol Assoc : 74-87
    › Primary publication · 30166701 (PubMed) · PMC6116582 (PubMed Central)
  41. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. Fontana RJ, Cirulli ET, Gu J, Kleiner D, Ostrov D, Phillips E, Schutte R, Barnhart H, Chalasani N, Watkins PB, Hoofnagle JH (2018) J Hepatol 69(6): 1317-1325
    › Primary publication · 30138689 (PubMed) · PMC6472700 (PubMed Central)
  42. Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Karnes JH, Miller MA, White KD, Konvinse KC, Pavlos RK, Redwood AJ, Peter JG, Lehloenya R, Mallal SA, Phillips EJ (2019) Annu Rev Pharmacol Toxicol : 463-486
    › Primary publication · 30134124 (PubMed) · PMC6409210 (PubMed Central)
  43. Defining Regional Differences in Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Tool to Improve Drug Safety? Phillips EJ (2019) Clin Pharmacol Ther 105(1): 22-25
    › Primary publication · 30120778 (PubMed) · PMC6312457 (PubMed Central)
  44. Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer. Trubiano JA, Grayson ML, Phillips EJ, Stewardson AJ, Thursky KA, Slavin MA (2018) J Antimicrob Chemother 73(11): 3209-3211
    › Primary publication · 30060208 (PubMed) · PMC6198745 (PubMed Central)
  45. Anaphylaxis after vaccination in a pediatric patient: further implicating alpha-gal allergy. Stone CA, Commins SP, Choudhary S, Vethody C, Heavrin JL, Wingerter J, Hemler JA, Babe K, Phillips EJ, Norton AE (2019) J Allergy Clin Immunol Pract 7(1): 322-324.e2
    › Primary publication · 29913263 (PubMed) · PMC6295282 (PubMed Central)
  46. How antibiotic allergy labels may be harming our most vulnerable patients. Trubiano JA, Grayson ML, Thursky KA, Phillips EJ, Slavin MA (2018) Med J Aust 208(11): 469-470
    › Primary publication · 29902399 (PubMed) · PMC6167469 (PubMed Central)
  47. Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis. Kim WB, Worley B, Holmes J, Phillips EJ, Beecker J (2018) J Am Acad Dermatol 79(6): 1150-1152
    › Primary publication · 29890189 (PubMed) · PMC6234072 (PubMed Central)
  48. Personalizing antiretroviral therapy: is it a reality? Phillips EJ, Mallal SA (2009) Per Med 6(4): 393-408
    › Primary publication · 29783545 (PubMed)
  49. Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration. Phillips EJ, Mallal SA (2018) J Clin Invest 128(7): 2746-2749
    › Primary publication · 29781810 (PubMed) · PMC6025972 (PubMed Central)
  50. Urinary Peptides As a Novel Source of T Cell Allergen Epitopes. da Silva Antunes R, Pham J, McMurtrey C, Hildebrand WH, Phillips E, Mallal S, Sidney J, Busse P, Peters B, Schulten V, Sette A (2018) Front Immunol : 886
    › Primary publication · 29755469 (PubMed) · PMC5932195 (PubMed Central)
  51. Antibiotic Allergy in Pediatrics. Norton AE, Konvinse K, Phillips EJ, Broyles AD (2018) Pediatrics 141(5)
    › Primary publication · 29700201 (PubMed) · PMC5914499 (PubMed Central)
  52. Antibiotic Use After Removal of Penicillin Allergy Label. Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Kibicho J, Brousseau DC (2018) Pediatrics 141(5)
    › Primary publication · 29678929 (PubMed) · PMC5914488 (PubMed Central)
  53. Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study. Cook KM, Gillon J, Grisso AG, Banerjee R, Jimenez-Truque N, Phillips EJ, Van Driest SL (2019) J Pediatric Infect Dis Soc 8(3): 221-227
    › Primary publication · 29590376 (PubMed) · PMC6601383 (PubMed Central)
  54. Correction: Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses. da Silva Antunes R, Paul S, Sidney J, Weiskopf D, Dan JM, Phillips E, Mallal S, Crotty S, Sette A, Lindestam Arlehamn CS (2018) PLoS One 13(2): e0193382
    › Primary publication · 29462188 (PubMed) · PMC5819815 (PubMed Central)
  55. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 159 individuals from the Worcester region of the Western Cape province of South Africa. Grifoni A, Sidney J, Carpenter C, Phillips E, Mallal S, Scriba TJ, Sette A, Lindestam Arlehamn CS (2018) Hum Immunol 79(3): 143-144
    › Primary publication · 29398200 (PubMed)
  56. Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. Phillips EJ, Sukasem C, Whirl-Carrillo M, Müller DJ, Dunnenberger HM, Chantratita W, Goldspiel B, Chen YT, Carleton BC, George AL, Mushiroda T, Klein T, Gammal RS, Pirmohamed M (2018) Clin Pharmacol Ther 103(4): 574-581
    › Primary publication · 29392710 (PubMed) · PMC5847474 (PubMed Central)
  57. Reply. Stone CA, Hemler JA, Commins SP, Schuyler AJ, Phillips EJ, Peebles RS, Fahrenholz JM (2018) J Allergy Clin Immunol 141(5): 1957-1958
    › Primary publication · 29370925 (PubMed) · PMC6298749 (PubMed Central)
  58. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, Chodosh J, Cibotti R, Davis R, Denny JC, Dodiuk-Gad RP, Ergen EN, Goldman JL, Holmes JH, Hung SI, Lacouture ME, Lehloenya RJ, Mallal S, Manolio TA, Micheletti RG, Mitchell CM, Mockenhaupt M, Ostrov DA, Pavlos R, Pirmohamed M, Pope E, Redwood A, Rosenbach M, Rosenblum MD, Roujeau JC, Saavedra AP, Saeed HN, Struewing JP, Sueki H, Sukasem C, Sung C, Trubiano JA, Weintraub J, Wheatley LM, Williams KB, Worley B, Chung WH, Shear NH, Phillips EJ (2018) J Allergy Clin Immunol Pract 6(1): 38-69
    › Primary publication · 29310768 (PubMed) · PMC5857362 (PubMed Central)
  59. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 714 adults from Colombo, Sri Lanka. Grifoni A, Weiskopf D, Lindestam Arlehamn CS, Angelo M, Leary S, Sidney J, Frazier A, Phillips E, Mallal S, Mack SJ, Tippalagama R, Goonewardana S, Premawansa S, Premawansa G, Wijewickrama A, De Silva AD, Sette A (2018) Hum Immunol 79(2): 87-88
    › Primary publication · 29289740 (PubMed) · PMC6378951 (PubMed Central)
  60. HLAs: Key regulators of T-cell-mediated drug hypersensitivity. Redwood AJ, Pavlos RK, White KD, Phillips EJ (2018) HLA 91(1): 3-16
    › Primary publication · 29171940 (PubMed) · PMC5743596 (PubMed Central)
  61. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 339 adults from Managua, Nicaragua. Weiskopf D, Grifoni A, Arlehamn CSL, Angelo M, Leary S, Sidney J, Frazier A, Mack SJ, Phillips E, Mallal S, Cerpas C, Balmaseda A, Harris E, Sette A (2018) Hum Immunol 79(1): 1-2
    › Primary publication · 29122684 (PubMed) · PMC5788571 (PubMed Central)
  62. Persistence of Penicillin Allergy-Reply. Trubiano JA, Adkinson NF, Phillips EJ (2017) JAMA 318(17): 1714-1715
    › Primary publication · 29114827 (PubMed)
  63. Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis. Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade L, Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SI, Lee MTM, Leeder JS, Lertora JJL, Mahasirimongkol S, McLeod HL, Mockenhaupt M, Pacanowski M, Phillips EJ, Pinheiro S, Pirmohamed M, Sung C, Suwankesawong W, Trepanier L, Tumminia SJ, Veenstra D, Yuliwulandari R, Shear NH (2018) Clin Pharmacol Ther 103(3): 390-394
    › Primary publication · 29105735 (PubMed) · PMC5805563 (PubMed Central)
  64. The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. Trubiano JA, Strautins K, Redwood AJ, Pavlos R, Konvinse KC, Aung AK, Slavin MA, Thursky KA, Grayson ML, Phillips EJ (2018) J Allergy Clin Immunol Pract 6(4): 1287-1296.e1
    › Primary publication · 29100867 (PubMed) · PMC5930120 (PubMed Central)
  65. Global Assessment of Dengue Virus-Specific CD4 T Cell Responses in Dengue-Endemic Areas. Grifoni A, Angelo MA, Lopez B, O'Rourke PH, Sidney J, Cerpas C, Balmaseda A, Silveira CGT, Maestri A, Costa PR, Durbin AP, Diehl SA, Phillips E, Mallal S, De Silva AD, Nchinda G, Nkenfou C, Collins MH, de Silva AM, Lim MQ, Macary PA, Tatullo F, Solomon T, Satchidanandam V, Desai A, Ravi V, Coloma J, Turtle L, Rivino L, Kallas EG, Peters B, Harris E, Sette A, Weiskopf D (2017) Front Immunol : 1309
    › Primary publication · 29081779 (PubMed) · PMC5646259 (PubMed Central)
  66. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans. Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE, Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A (2017) J Virol 91(24)
    › Primary publication · 28978707 (PubMed) · PMC5709580 (PubMed Central)
  67. Cytomegalovirus (CMV) Epitope-Specific CD4 T Cells Are Inflated in HIV CMV Subjects. Abana CO, Pilkinton MA, Gaudieri S, Chopra A, McDonnell WJ, Wanjalla C, Barnett L, Gangula R, Hager C, Jung DK, Engelhardt BG, Jagasia MH, Klenerman P, Phillips EJ, Koelle DM, Kalams SA, Mallal SA (2017) J Immunol 199(9): 3187-3201
    › Primary publication · 28972094 (PubMed) · PMC5679304 (PubMed Central)
  68. Severe Delayed Drug Reactions: Role of Genetics and Viral Infections. Pavlos R, White KD, Wanjalla C, Mallal SA, Phillips EJ (2017) Immunol Allergy Clin North Am 37(4): 785-815
    › Primary publication · 28965641 (PubMed) · PMC5702581 (PubMed Central)
  69. A survey of drug allergy training opportunities in the United States. Derrick MI, Williams KB, Shade LMP, Phillips EJ (2018) J Allergy Clin Immunol Pract 6(1): 302-304
    › Primary publication · 28958742 (PubMed) · PMC5760283 (PubMed Central)
  70. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Bosch I, de Puig H, Hiley M, Carré-Camps M, Perdomo-Celis F, Narváez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, Gélvez-Ramírez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Muñóz-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, Díaz FJ, Restrepo BN, Marín K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, Gómez-Márquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L (2017) Sci Transl Med 9(409)
    › Primary publication · 28954927 (PubMed) · PMC6612058 (PubMed Central)
  71. Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptides. Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Arlehamn CSL, Sette A (2017) Nature 549(7671): 292
    › Primary publication · 28905919 (PubMed)
  72. Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients. Urbancic KF, Ierino F, Phillips E, Mount PF, Mahony A, Trubiano JA (2018) Am J Transplant 18(2): 462-466
    › Primary publication · 28898546 (PubMed) · PMC5790633 (PubMed Central)
  73. The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration. Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, Phillips EJ (2017) J Allergy Clin Immunol Pract 5(6): 1532-1542
    › Primary publication · 28843343 (PubMed) · PMC5681410 (PubMed Central)
  74. Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Pavlos R, McKinnon EJ, Ostrov DA, Peters B, Buus S, Koelle D, Chopra A, Schutte R, Rive C, Redwood A, Restrepo S, Bracey A, Kaever T, Myers P, Speers E, Malaker SA, Shabanowitz J, Jing Y, Gaudieri S, Hunt DF, Carrington M, Haas DW, Mallal S, Phillips EJ (2017) Sci Rep 7(1): 8653
    › Primary publication · 28819312 (PubMed) · PMC5561238 (PubMed Central)
  75. Genomic testing as a tool to optimise drug therapy. Somogyi AA, Phillips E (2017) Aust Prescr 40(3): 101-104
    › Primary publication · 28798515 (PubMed) · PMC5478394 (PubMed Central)
  76. Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT). Karnes JH, Shaffer CM, Cronin R, Bastarache L, Gaudieri S, James I, Pavlos R, Steiner HE, Mosley JD, Mallal S, Denny JC, Phillips EJ, Roden DM (2017) Pharmacotherapy 37(9): 1164-1171
    › Primary publication · 28688202 (PubMed) · PMC5600645 (PubMed Central)
  77. Penicillin Allergy Is Not Necessarily Forever. Trubiano JA, Adkinson NF, Phillips EJ (2017) JAMA 318(1): 82-83
    › Primary publication · 28672303 (PubMed) · PMC5935455 (PubMed Central)
  78. T cells from patients with Parkinson's disease recognize α-synuclein peptides. Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A (2017) Nature 546(7660): 656-661
    › Primary publication · 28636593 (PubMed) · PMC5626019 (PubMed Central)
  79. Cobicistat Versus Ritonavir: Similar Pharmacokinetic Enhancers But Some Important Differences. Tseng A, Hughes CA, Wu J, Seet J, Phillips EJ (2017) Ann Pharmacother 51(11): 1008-1022
    › Primary publication · 28627229 (PubMed) · PMC5702580 (PubMed Central)
  80. Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Trubiano JA, Thursky KA, Stewardson AJ, Urbancic K, Worth LJ, Jackson C, Stevenson W, Sutherland M, Slavin MA, Grayson ML, Phillips EJ (2017) Clin Infect Dis 65(1): 166-174
    › Primary publication · 28520865 (PubMed) · PMC5849110 (PubMed Central)
  81. Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants. Karnes JH, Bastarache L, Shaffer CM, Gaudieri S, Xu Y, Glazer AM, Mosley JD, Zhao S, Raychaudhuri S, Mallal S, Ye Z, Mayer JG, Brilliant MH, Hebbring SJ, Roden DM, Phillips EJ, Denny JC (2017) Sci Transl Med 9(389)
    › Primary publication · 28490672 (PubMed) · PMC5563969 (PubMed Central)
  82. Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. Peter JG, Lehloenya R, Dlamini S, Risma K, White KD, Konvinse KC, Phillips EJ (2017) J Allergy Clin Immunol Pract 5(3): 547-563
    › Primary publication · 28483310 (PubMed) · PMC5424615 (PubMed Central)
  83. Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. Thomas M, Hopkins C, Duffy E, Lee D, Loulergue P, Ripamonti D, Ostrov DA, Phillips E (2017) Clin Infect Dis 64(9): 1198-1203
    › Primary publication · 28369189 (PubMed) · PMC5399947 (PubMed Central)
  84. Pharmacogenomics of off-target adverse drug reactions. Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA, Phillips EJ (2017) Br J Clin Pharmacol 83(9): 1896-1911
    › Primary publication · 28345177 (PubMed) · PMC5555876 (PubMed Central)
  85. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya. Arlehamn CS, Copin R, Leary S, Mack SJ, Phillips E, Mallal S, Sette A, Blatner G, Siefers H, Ernst JD, TBRU-ASTRa Study Team (2017) Hum Immunol 78(4): 325-326
    › Primary publication · 28315719 (PubMed) · PMC5519768 (PubMed Central)
  86. Recent advances in the understanding of severe cutaneous adverse reactions. Adler NR, Aung AK, Ergen EN, Trubiano J, Goh MSY, Phillips EJ (2017) Br J Dermatol 177(5): 1234-1247
    › Primary publication · 28256714 (PubMed) · PMC5582023 (PubMed Central)
  87. AdDRESSing T-cell responses to antituberculous drugs. Pavlos R, Redwood A, Phillips E (2017) Br J Dermatol 176(2): 292-293
    › Primary publication · 28244076 (PubMed) · PMC5429398 (PubMed Central)
  88. Comparison of HLA allelic imputation programs. Karnes JH, Shaffer CM, Bastarache L, Gaudieri S, Glazer AM, Steiner HE, Mosley JD, Mallal S, Denny JC, Phillips EJ, Roden DM (2017) PLoS One 12(2): e0172444
    › Primary publication · 28207879 (PubMed) · PMC5312875 (PubMed Central)
  89. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. Grifoni A, Angelo M, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA, Botten J, Boyson J, Kirkpatrick BD, Whitehead SS, Durbin AP, Sette A, Weiskopf D (2017) J Virol 91(8)
    › Primary publication · 28148797 (PubMed) · PMC5375662 (PubMed Central)
  90. Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses. da Silva Antunes R, Paul S, Sidney J, Weiskopf D, Dan JM, Phillips E, Mallal S, Crotty S, Sette A, Lindestam Arlehamn CS (2017) PLoS One 12(1): e0169086
    › Primary publication · 28081174 (PubMed) · PMC5230748 (PubMed Central)
  91. Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism. Stone CA, Hemler JA, Commins SP, Schuyler AJ, Phillips EJ, Peebles RS, Fahrenholz JM (2017) J Allergy Clin Immunol 139(5): 1710-1713.e2
    › Primary publication · 27986511 (PubMed) · PMC5420485 (PubMed Central)
  92. Human CD4 T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity. Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA, Kirkpatrick BD, Whitehead SS, Durbin AP, Sette A, Weiskopf D (2017) J Virol 91(5)
    › Primary publication · 27974563 (PubMed) · PMC5309943 (PubMed Central)
  93. Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis. Trubiano JA, Redwood A, Strautins K, Pavlos R, Woolnough E, Chang CC, Phillips E (2017) J Allergy Clin Immunol Pract 5(3): 823-826
    › Primary publication · 27888029 (PubMed) · PMC5436601 (PubMed Central)
  94. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander MR, Bloomer TL, Becker JR, Slosky DA, Phillips EJ, Pilkinton MA, Craig-Owens L, Kola N, Plautz G, Reshef DS, Deutsch JS, Deering RP, Olenchock BA, Lichtman AH, Roden DM, Seidman CE, Koralnik IJ, Seidman JG, Hoffman RD, Taube JM, Diaz LA, Anders RA, Sosman JA, Moslehi JJ (2016) N Engl J Med 375(18): 1749-1755
    › Primary publication · 27806233 (PubMed) · PMC5247797 (PubMed Central)
  95. Improving Antimicrobial Stewardship by Antibiotic Allergy Delabeling: Evaluation of Knowledge, Attitude, and Practices Throughout the Emerging Infections Network. Trubiano JA, Beekmann SE, Worth LJ, Polgreen PM, Thursky KA, Slavin MA, Grayson ML, Phillips EJ (2016) Open Forum Infect Dis 3(3): ofw153
    › Primary publication · 27800527 (PubMed) · PMC5084721 (PubMed Central)
  96. Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity. Konvinse KC, Phillips EJ, White KD, Trubiano JA (2016) Curr Opin Infect Dis 29(6): 561-576
    › Primary publication · 27753687 (PubMed) · PMC5113146 (PubMed Central)
  97. Return to sender: the need to re-address patient antibiotic allergy labels in Australia and New Zealand. Trubiano JA, Worth LJ, Urbancic K, Brown TM, Paterson DL, Australasian Society for Infectious Diseases Clinical Research Network, Lucas M, Australasian Society of Clinical Immunology and Allergy, Phillips E (2016) Intern Med J 46(11): 1311-1317
    › Primary publication · 27527526 (PubMed) · PMC5096978 (PubMed Central)
  98. HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses. Weiskopf D, Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, De Silva AD, Phillips E, Mallal S, Premawansa S, Premawansa G, Wijewickrama A, Peters B, Sette A (2016) J Infect Dis 214(7): 1117-24
    › Primary publication · 27443615 (PubMed) · PMC5021234 (PubMed Central)
  99. Identifying genetically driven clinical phenotypes using linear mixed models. Mosley JD, Witte JS, Larkin EK, Bastarache L, Shaffer CM, Karnes JH, Stein CM, Phillips E, Hebbring SJ, Brilliant MH, Mayer J, Ye Z, Roden DM, Denny JC (2016) Nat Commun : 11433
    › Primary publication · 27109359 (PubMed) · PMC4848547 (PubMed Central)
  100. Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses. Jing L, Laing KJ, Dong L, Russell RM, Barlow RS, Haas JG, Ramchandani MS, Johnston C, Buus S, Redwood AJ, White KD, Mallal SA, Phillips EJ, Posavad CM, Wald A, Koelle DM (2016) J Immunol 196(5): 2205-2218
    › Primary publication · 26810224 (PubMed) · PMC4761520 (PubMed Central)
  101. Mechanism of isoniazid-induced hepatotoxicity: then and now. Metushi I, Uetrecht J, Phillips E (2016) Br J Clin Pharmacol 81(6): 1030-6
    › Primary publication · 26773235 (PubMed) · PMC4876174 (PubMed Central)
  102. The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. Hemler JA, Phillips EJ, Mallal SA, Kendall PL (2015) Ann Allergy Asthma Immunol 115(6): 471-6
    › Primary publication · 26522257 (PubMed) · PMC5665015 (PubMed Central)
  103. Classifying ADRs--does dose matter? Phillips EJ (2016) Br J Clin Pharmacol 81(1): 10-2
    › Primary publication · 26286675 (PubMed) · PMC4693569 (PubMed Central)
  104. Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. Wheatley LM, Plaut M, Schwaninger JM, Banerji A, Castells M, Finkelman FD, Gleich GJ, Guttman-Yassky E, Mallal SA, Naisbitt DJ, Ostrov DA, Phillips EJ, Pichler WJ, Platts-Mills TA, Roujeau JC, Schwartz LB, Trepanier LA (2015) J Allergy Clin Immunol 136(2): 262-71.e2
    › Primary publication · 26254053 (PubMed) · PMC4529958 (PubMed Central)
  105. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. White KD, Chung WH, Hung SI, Mallal S, Phillips EJ (2015) J Allergy Clin Immunol 136(2): 219-34; quiz 235
    › Primary publication · 26254049 (PubMed) · PMC4577472 (PubMed Central)
  106. Penicillin allergy label persists despite negative testing. Gerace KS, Phillips E (2015) J Allergy Clin Immunol Pract 3(5): 815-6
    › Primary publication · 26143017 (PubMed)
  107. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Saito Y, Stamp LK, Caudle KE, Hershfield MS, McDonagh EM, Callaghan JT, Tassaneeyakul W, Mushiroda T, Kamatani N, Goldspiel BR, Phillips EJ, Klein TE, Lee MT, Clinical Pharmacogenetics Implementation Consortium (2016) Clin Pharmacol Ther 99(1): 36-7
    › Primary publication · 26094938 (PubMed) · PMC4675696 (PubMed Central)
  108. Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity. Metushi IG, Wriston A, Banerjee P, Gohlke BO, English AM, Lucas A, Moore C, Sidney J, Buus S, Ostrov DA, Mallal S, Phillips E, Shabanowitz J, Hunt DF, Preissner R, Peters B (2015) PLoS One 10(5): e0124878
    › Primary publication · 26024233 (PubMed) · PMC4449000 (PubMed Central)
  109. Varying penicillin allergy testing practices in the United States: A time for consensus. Gerace KS, Karlin E, McKinnon E, Phillips E (2015) J Allergy Clin Immunol Pract 3(5): 791-3
    › Primary publication · 25920344 (PubMed)
  110. Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study. Sterling TR, Moro RN, Borisov AS, Phillips E, Shepherd G, Adkinson NF, Weis S, Ho C, Villarino ME, Tuberculosis Trials Consortium (2015) Clin Infect Dis 61(4): 527-35
    › Primary publication · 25904367 (PubMed) · PMC4560029 (PubMed Central)
  111. Abacavir-reactive memory T cells are present in drug naïve individuals. Lucas A, Lucas M, Strhyn A, Keane NM, McKinnon E, Pavlos R, Moran EM, Meyer-Pannwitt V, Gaudieri S, D'Orsogna L, Kalams S, Ostrov DA, Buus S, Peters B, Mallal S, Phillips E (2015) PLoS One 10(2): e0117160
    › Primary publication · 25674793 (PubMed) · PMC4326126 (PubMed Central)
  112. Improving the Effectiveness of Penicillin Allergy De-labeling. Bourke J, Pavlos R, James I, Phillips E (2015) J Allergy Clin Immunol Pract 3(3): 365-34.e1
    › Primary publication · 25609352 (PubMed)
  113. Pharmacogenomics of antimicrobial agents. Aung AK, Haas DW, Hulgan T, Phillips EJ (2014) Pharmacogenomics 15(15): 1903-30
    › Primary publication · 25495412 (PubMed) · PMC4296903 (PubMed Central)
  114. T cell-mediated hypersensitivity reactions to drugs. Pavlos R, Mallal S, Ostrov D, Buus S, Metushi I, Peters B, Phillips E (2015) Annu Rev Med : 439-54
    › Primary publication · 25386935 (PubMed) · PMC4295772 (PubMed Central)
  115. Antiviral drug allergy. Milpied-Homsi B, Moran EM, Phillips EJ (2014) Immunol Allergy Clin North Am 34(3): 645-62, ix
    › Primary publication · 25017682 (PubMed) · PMC4140860 (PubMed Central)
  116. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Tseng A, Seet J, Phillips EJ (2015) Br J Clin Pharmacol 79(2): 182-94
    › Primary publication · 24730660 (PubMed) · PMC4309625 (PubMed Central)
  117. Response to letter regarding article 'Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis'. Brusch AM, Clarke RC, Platt PR, Phillips E (2014) Br J Clin Pharmacol 78(4): 931-2
    › Primary publication · 24611979 (PubMed) · PMC4239987 (PubMed Central)
  118. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. Pavlos R, Mallal S, Ostrov D, Pompeu Y, Phillips E (2014) J Allergy Clin Immunol Pract 2(1): 21-33
    › Primary publication · 24565765 (PubMed) · PMC4020624 (PubMed Central)
  119. Genotyping for severe drug hypersensitivity. Karlin E, Phillips E (2014) Curr Allergy Asthma Rep 14(3): 418
    › Primary publication · 24429903 (PubMed) · PMC4014135 (PubMed Central)
  120. Immediate-type hypersensitivity drug reactions. Stone SF, Phillips EJ, Wiese MD, Heddle RJ, Brown SG (2014) Br J Clin Pharmacol 78(1): 1-13
    › Primary publication · 24286446 (PubMed) · PMC4168374 (PubMed Central)
  121. Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. Brusch AM, Clarke RC, Platt PR, Phillips EJ (2014) Br J Clin Pharmacol 78(1): 14-23
    › Primary publication · 24251966 (PubMed) · PMC4168376 (PubMed Central)
  122. Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'. Trubiano J, Phillips E (2013) Curr Opin Infect Dis 26(6): 526-37
    › Primary publication · 24126717 (PubMed) · PMC3862073 (PubMed Central)
  123. HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Hertz T, Oshansky CM, Roddam PL, DeVincenzo JP, Caniza MA, Jojic N, Mallal S, Phillips E, James I, Halloran ME, Thomas PG, Corey L (2013) Proc Natl Acad Sci U S A 110(33): 13492-7
    › Primary publication · 23878211 (PubMed) · PMC3746844 (PubMed Central)
  124. Testing for drug hypersensitivity syndromes. Rive CM, Bourke J, Phillips EJ (2013) Clin Biochem Rev 34(1): 15-38
    › Primary publication · 23592889 (PubMed) · PMC3626363 (PubMed Central)
  125. Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. Phillips E, Bartlett JA, Sanne I, Lederman MM, Hinkle J, Rousseau F, Dunn D, Pavlos R, James I, Mallal SA, Haas DW (2013) J Acquir Immune Defic Syndr 62(2): e55-7
    › Primary publication · 23328091 (PubMed) · PMC3551216 (PubMed Central)
  126. HLA-B*5701 and flucloxacillin associated drug-induced liver disease. Phillips EJ, Mallal SA (2013) AIDS 27(3): 491-2
    › Primary publication · 23291545 (PubMed)
  127. Individualization of antiretroviral therapy. Pavlos R, Phillips EJ (2012) Pharmgenomics Pers Med : 1-17
    › Primary publication · 23226059 (PubMed) · PMC3513193 (PubMed Central)
  128. The structural basis of HLA-associated drug hypersensitivity syndromes. Pompeu YA, Stewart JD, Mallal S, Phillips E, Peters B, Ostrov DA (2012) Immunol Rev 250(1): 158-66
    › Primary publication · 23046128 (PubMed)
  129. Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. McGettigan BD, Hew M, Phillips E, McLean-Tooke A (2012) BMJ Case Rep
    › Primary publication · 23001098 (PubMed) · PMC4543738 (PubMed Central)
  130. HLA and pharmacogenetics of drug hypersensitivity. Pavlos R, Mallal S, Phillips E (2012) Pharmacogenomics 13(11): 1285-306
    › Primary publication · 22920398 (PubMed)
  131. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B (2012) Proc Natl Acad Sci U S A 109(25): 9959-64
    › Primary publication · 22645359 (PubMed) · PMC3382472 (PubMed Central)
  132. Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. Haas DW, Kuritzkes DR, Ritchie MD, Amur S, Gage BF, Maartens G, Masys D, Fellay J, Phillips E, Ribaudo HJ, Freedberg KA, Petropoulos C, Manolio TA, Gulick RM, Haubrich R, Kim P, Dehlinger M, Abebe R, Telenti A, Workshop Pharmacogenomics-A Path Towards Personalized HIV Care (2011) HIV Clin Trials 12(5): 277-85
    › Primary publication · 22180526 (PubMed) · PMC3322423 (PubMed Central)
  133. HLA-B*1502 screening and toxic effects of carbamazepine. Phillips EJ, Mallal SA (2011) N Engl J Med 365(7): 672; author reply 673
    › Primary publication · 21848472 (PubMed)
  134. Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status? Lee MH, Stocker SL, Anderson J, Phillips EJ, Nolan D, Williams KM, Graham GG, Sullivan JR, Day RO (2012) Intern Med J 42(4): 411-6
    › Primary publication · 21790926 (PubMed)
  135. Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Hammond E, McKinnon E, Glendenning P, Williams R, Mallal S, Phillips E (2012) Clin Endocrinol (Oxf) 76(2): 201-6
    › Primary publication · 21682759 (PubMed)
  136. Phenotype standardization for immune-mediated drug-induced skin injury. Pirmohamed M, Friedmann PS, Molokhia M, Loke YK, Smith C, Phillips E, La Grenade L, Carleton B, Papaluca-Amati M, Demoly P, Shear NH (2011) Clin Pharmacol Ther 89(6): 896-901
    › Primary publication · 21562486 (PubMed)
  137. Drug hypersensitivity: pharmacogenetics and clinical syndromes. Phillips EJ, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA (2011) J Allergy Clin Immunol 127(3 Suppl): S60-6
    › Primary publication · 21354501 (PubMed) · PMC3061439 (PubMed Central)
  138. Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. Hertz T, Nolan D, James I, John M, Gaudieri S, Phillips E, Huang JC, Riadi G, Mallal S, Jojic N (2011) J Virol 85(3): 1310-21
    › Primary publication · 21084470 (PubMed) · PMC3020499 (PubMed Central)
  139. Pharmacogenetics of drug hypersensitivity. Phillips EJ, Mallal SA (2010) Pharmacogenomics 11(7): 973-87
    › Primary publication · 20602616 (PubMed) · PMC2937181 (PubMed Central)
  140. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Chaubey SK, Sinha AK, Phillips E, Russell DB, Falhammar H (2009) Sex Health 6(3): 254-7
    › Primary publication · 19653965 (PubMed)
  141. HLA and drug-induced toxicity. Phillips EJ, Mallal SA (2009) Curr Opin Mol Ther 11(3): 231-42
    › Primary publication · 19479656 (PubMed)
  142. The pharmacogenetics of antiretroviral therapy. Phillips EJ (2006) Curr Opin HIV AIDS 1(3): 249-56
    › Primary publication · 19372817 (PubMed)
  143. Successful translation of pharmacogenetics into the clinic: the abacavir example. Phillips E, Mallal S (2009) Mol Diagn Ther 13(1): 1-9
    › Primary publication · 19351209 (PubMed)
  144. Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Rauch A, Nolan D, Thurnheer C, Fux CA, Cavassini M, Chave JP, Opravil M, Phillips E, Mallal S, Furrer H, Swiss HIV Cohort Study (2008) Antivir Ther 13(8): 1019-28
    › Primary publication · 19195327 (PubMed)
  145. A review of drug patch testing and implications for HIV clinicians. Shear NH, Milpied B, Bruynzeel DP, Phillips EJ (2008) AIDS 22(9): 999-1007
    › Primary publication · 18520343 (PubMed)
  146. Cytokine profiling in abacavir hypersensitivity patients. Almeida CA, Martin AM, Nolan D, Lucas A, Cameron PU, James I, Phillips E, Mallal S (2008) Antivir Ther 13(2): 281-8
    › Primary publication · 18505179 (PubMed)
  147. High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Saag M, Balu R, Phillips E, Brachman P, Martorell C, Burman W, Stancil B, Mosteller M, Brothers C, Wannamaker P, Hughes A, Sutherland-Phillips D, Mallal S, Shaefer M, Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team (2008) Clin Infect Dis 46(7): 1111-8
    › Primary publication · 18444831 (PubMed)
  148. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply. Phillips E, Hayden A, Gutiérrez S, Jahnke N, Yip B, Lima VD, Hogg RS, Harrigan PR, Montaner JS (2008) AIDS 22(4): 548-9
    › Primary publication · 18301076 (PubMed)
  149. HLA-B*5701 screening for hypersensitivity to abacavir. Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A, PREDICT-1 Study Team (2008) N Engl J Med 358(6): 568-79
    › Primary publication · 18256392 (PubMed)
  150. Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Phillips EJ, Mallal SA (2008) Curr Opin Infect Dis 21(1): 16-24
    › Primary publication · 18192781 (PubMed)
  151. External quality assessment of HLA-B*5701 reporting: an international multicentre survey. Hammond E, Almeida CA, Mamotte C, Nolan D, Phillips E, Schollaardt TA, Gill MJ, Angel JB, Neurath D, Li J, Giulivi T, McIntyre C, Koultchitski G, Wong B, Reis M, Rachlis A, Cole DE, Chew CB, Neifer S, Lalonde R, Roger M, Jeanneau A, Mallal S (2007) Antivir Ther 12(7): 1027-32
    › Primary publication · 18018760 (PubMed)
  152. An estimate of the proportion of symptoms reported in self-administered questionnaires that are captured as adverse drug events in an observational database. Raboud J, Lesosky M, Sterling S, Phillips E, Walmsley S, Bayoumi A (2007) HIV Clin Trials 8(5): 311-9
    › Primary publication · 17956832 (PubMed)
  153. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients. Phillips E, Gutiérrez S, Jahnke N, Yip B, Lima VD, Hogg RS, Harrigan PR, Montaner JS (2007) AIDS 21(12): 1561-8
    › Primary publication · 17630551 (PubMed)
  154. Drug hypersensitivity in HIV. Phillips E, Mallal S (2007) Curr Opin Allergy Clin Immunol 7(4): 324-30
    › Primary publication · 17620824 (PubMed)
  155. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Tansey CM, Louie M, Loeb M, Gold WL, Muller MP, de Jager J, Cameron JI, Tomlinson G, Mazzulli T, Walmsley SL, Rachlis AR, Mederski BD, Silverman M, Shainhouse Z, Ephtimios IE, Avendano M, Downey J, Styra R, Yamamura D, Gerson M, Stanbrook MB, Marras TK, Phillips EJ, Zamel N, Richardson SE, Slutsky AS, Herridge MS (2007) Arch Intern Med 167(12): 1312-20
    › Primary publication · 17592106 (PubMed)
  156. Immune responses to abacavir in antigen-presenting cells from hypersensitive patients. Martin AM, Almeida CA, Cameron P, Purcell AW, Nolan D, James I, McCluskey J, Phillips E, Landay A, Mallal S (2007) AIDS 21(10): 1233-44
    › Primary publication · 17545699 (PubMed)
  157. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Chui CK, Brumme ZL, Brumme CJ, Yip B, Phillips EJ, Montaner JS, Harrigan PR (2007) Clin Infect Dis 44(11): 1503-8
    › Primary publication · 17479950 (PubMed)
  158. Outbreak of acupuncture-associated cutaneous Mycobacterium abscessus infections. Tang P, Walsh S, Murray C, Alterman C, Varia M, Broukhanski G, Chedore P, DeKoven J, Assaad D, Gold WL, Ghazarian D, Finkelstein M, Pritchard M, Yaffe B, Jamieson F, Henry B, Phillips E (2006) J Cutan Med Surg 10(4): 166-9
    › Primary publication · 17234114 (PubMed)
  159. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A (2007) Clin Infect Dis 44(2): 178-85
    › Primary publication · 17173213 (PubMed)
  160. Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet? Phillips EJ (2006) Clin Infect Dis 43(1): 103-5
    › Primary publication · 16758425 (PubMed)
  161. A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe. Thistle P, Gottesman M, Pilon R, Glazier RH, Arbess G, Phillips E, Wald RL, Chitsike I, Simor A, Chipato T, Silverman M (2004) Cent Afr J Med 50(9-10): 79-84
    › Primary publication · 16411341 (PubMed)
  162. Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance. Nolan D, Phillips E, Mallal S (2006) Clin Infect Dis 42(3): 408-10
    › Primary publication · 16392090 (PubMed)
  163. Clindamycin skin testing has limited diagnostic potential. Notman MJ, Phillips EJ, Knowles SR, Weber EA, Shear NH (2005) Contact Dermatitis 53(6): 335-8
    › Primary publication · 16364122 (PubMed)
  164. Steady-state pharmacokinetics and tolerability of indinavir-lopinavir/r combination therapy in antiretroviral-experienced patients. Antoniou T, Tseng AL, van Heeswijk RP, Walker SE, Giguere P, Phillips EJ (2005) Ther Drug Monit 27(6): 779-81
    › Primary publication · 16306854 (PubMed)
  165. Effect of high-dose vitamin C on hepatic cytochrome P450 3A4 activity. van Heeswijk RP, Cooper CL, Foster BC, Chauhan BM, Shirazi F, Seguin I, Phillips EJ, Mills E (2005) Pharmacotherapy 25(12): 1725-8
    › Primary publication · 16305291 (PubMed)
  166. Hydrochlorothiazide-induced noncardiogenic pulmonary edema: an underrecognized yet serious adverse drug reaction. Knowles SR, Wong GA, Rahim SA, Binkley K, Phillips EJ, Shear NH (2005) Pharmacotherapy 25(9): 1258-65
    › Primary publication · 16164399 (PubMed)
  167. Comment: Sulfonamide cross-reactivity: fact or fiction? Phillips EJ, Knowles SR (2005) Ann Pharmacother 39(7-8): 1372-3; author reply 1373
    › Primary publication · 15928263 (PubMed)
  168. Clinical and immunogenetic correlates of abacavir hypersensitivity. Phillips EJ, Wong GA, Kaul R, Shahabi K, Nolan DA, Knowles SR, Martin AM, Mallal SA, Shear NH (2005) AIDS 19(9): 979-81
    › Primary publication · 15905681 (PubMed)
  169. Natural health product-HIV drug interactions: a systematic review. Mills E, Montori V, Perri D, Phillips E, Koren G (2005) Int J STD AIDS 16(3): 181-6
    › Primary publication · 15829016 (PubMed)
  170. Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis. Mills E, Wilson K, Clarke M, Foster B, Walker S, Rachlis B, DeGroot N, Montori VM, Gold W, Phillips E, Myers S, Gallicano K (2005) Eur J Clin Pharmacol 61(1): 1-7
    › Primary publication · 15666173 (PubMed)
  171. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts. Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S (2005) AIDS 19(1): 97-9
    › Primary publication · 15627041 (PubMed)
  172. Impact of African herbal medicines on antiretroviral metabolism. Mills E, Foster BC, van Heeswijk R, Phillips E, Wilson K, Leonard B, Kosuge K, Kanfer I (2005) AIDS 19(1): 95-7
    › Primary publication · 15627040 (PubMed)
  173. The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. van Heeswijk RP, Khaliq Y, Gallicano KD, Bourbeau M, Seguin I, Phillips EJ, Cameron DW (2004) Clin Pharmacol Ther 76(6): 588-97
    › Primary publication · 15592330 (PubMed)
  174. Serious dermatologic reaction associated with valdecoxib: report of two cases. Knowles SR, Phillips EJ, Wong G, Shear NH (2004) J Am Acad Dermatol 51(6): 1028-9
    › Primary publication · 15583610 (PubMed)
  175. Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity. Martin AM, Nolan D, Gaudieri S, Phillips E, Mallal S (2004) Pharmacogenomics 5(6): 643-55
    › Primary publication · 15335286 (PubMed)
  176. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, McCluskey J, Mallal S (2004) Proc Natl Acad Sci U S A 101(12): 4180-5
    › Primary publication · 15024131 (PubMed) · PMC384715 (PubMed Central)
  177. Challenges of adherence management in human immunodeficiency virus pharmacotherapy. Park-Wyllie LY, Phillips EJ (2003) Can J Clin Pharmacol 10(4): 189-95
    › Primary publication · 14712324 (PubMed)
  178. Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. Tang P, Louie M, Richardson SE, Smieja M, Simor AE, Jamieson F, Fearon M, Poutanen SM, Mazzulli T, Tellier R, Mahony J, Loeb M, Petrich A, Chernesky M, McGeer A, Low DE, Phillips E, Jones S, Bastien N, Li Y, Dick D, Grolla A, Fernando L, Booth TF, Henry B, Rachlis AR, Matukas LM, Rose DB, Lovinsky R, Walmsley S, Gold WL, Krajden S, Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Infections (2004) CMAJ 170(1): 47-54
    › Primary publication · 14707219 (PubMed) · PMC305313 (PubMed Central)
  179. Serum sickness-like reaction associated with clopidogrel. Phillips EJ, Knowles SR, Shear NH (2003) Br J Clin Pharmacol 56(5): 583
    › Primary publication · 14651737 (PubMed) · PMC1884383 (PubMed Central)
  180. Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy. Loutfy M, Raboud J, Thompson C, Tseng A, Abdurrahman Z, Kovacs C, Rachlis A, Phillips E, Rubin G, Gough K, Walmsley S (2003) HIV Clin Trials 4(5): 301-10
    › Primary publication · 14583846 (PubMed)
  181. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Knowles SR, Phillips EJ, Dresser L, Matukas L (2003) Clin Infect Dis 37(8): 1139-42
    › Primary publication · 14523782 (PubMed) · PMC7204073 (PubMed Central)
  182. Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein? Phillips EJ, Rachlis AR, Ito S (2003) AIDS 17(10): 1577-8
    › Primary publication · 12824804 (PubMed)
  183. Cutaneous manifestations of antiviral therapy. Phillips EJ, Knowles SR, Shear N (2003) J Am Acad Dermatol 48(6): 985-6
    › Primary publication · 12789204 (PubMed)
  184. Clindamycin-associated acute generalized exanthematous pustulosis. Valois M, Phillips EJ, Shear NH, Knowles SR (2003) Contact Dermatitis 48(3): 169
    › Primary publication · 12755740 (PubMed)
  185. 'Buffalo-hump' dermatitis: a hat trick of antiretroviral side-effects. Sullivan JR, Rachlis A, Phillips E (2003) Contact Dermatitis 48(3): 169-70
    › Primary publication · 12755739 (PubMed)
  186. Ribavirin in the treatment of SARS: A new trick for an old drug? Koren G, King S, Knowles S, Phillips E (2003) CMAJ 168(10): 1289-92
    › Primary publication · 12743076 (PubMed) · PMC154189 (PubMed Central)
  187. Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals. Neuman MG, Malkiewicz IM, Phillips EJ, Rachlis AR, Ong D, Yeung E, Shear NH (2002) Ther Drug Monit 24(6): 728-36
    › Primary publication · 12451289 (PubMed)
  188. The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond? Phillips EJ, Tseng A (2002) Can J Clin Pharmacol 9(3): 120-2
    › Primary publication · 12422248 (PubMed)
  189. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. Phillips EJ, Sullivan JR, Knowles SR, Shear NH (2002) AIDS 16(16): 2223-5
    › Primary publication · 12409746 (PubMed)
  190. Efavirenz-induced skin eruption and successful desensitization. Phillips EJ, Kuriakose B, Knowles SR (2002) Ann Pharmacother 36(3): 430-2
    › Primary publication · 11895054 (PubMed)
  191. Itraconazole was as effective as amphotericin B for fever and neutropenia in cancer and led to fewer adverse events. Phillips EJ (2002) ACP J Club 136(2): 58
    › Primary publication · 11874283 (PubMed)
  192. Cephalexin tolerated despite delayed aminopenicillin reactions. Phillips E, Knowles SR, Weber EA, Blackburn D (2001) Allergy 56(8): 790
    › Primary publication · 11488680 (PubMed)
  193. Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic. Phillips E, Louie M, Knowles SR, Simor AE, Oh PI (2000) Am J Health Syst Pharm 57(4): 339-45
    › Primary publication · 10714971 (PubMed)
  194. Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management. Phillips E, Knowles S, Weber E, Shear NH (1998) J Allergy Clin Immunol 102(4 Pt 1): 697-8
    › Primary publication · 9802383 (PubMed)
  195. Toxoplasmosis. Phillips E (1998) Can Fam Physician : 1823-5, 1827
    › Primary publication · 9789661 (PubMed) · PMC2277878 (PubMed Central)
  196. Rapid onset of risperidone-induced hepatotoxicity. Phillips EJ, Liu BA, Knowles SR (1998) Ann Pharmacother 32(7-8): 843
    › Primary publication · 9681106 (PubMed)
  197. Bacterial meningitis in children and adults. Changes in community-acquired disease may affect patient care. Phillips EJ, Simor AE (1998) Postgrad Med 103(3): 102-117
    › Primary publication · 9519033 (PubMed)
  198. The effect of exercise on lymphocyte redistribution and leucocyte function in asymptomatic HIV-infected subjects. Phillips EJ, Ottaway CA, Freedman J, Kardish M, Li J, Singer W, Fong IW (1997) Brain Behav Immun 11(3): 217-27
    › Primary publication · 9417806 (PubMed)
  199. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Phillips EJ, Keystone JS, Kain KC (1996) Clin Infect Dis 23(5): 1171-3
    › Primary publication · 8922821 (PubMed)
  200. Human T-lymphotropic virus: exposure and prognosis. Soskolne CL, Heyland D, Phillips E (1986) CMAJ 134(6): 575-7
    › Primary publication · 3004687 (PubMed) · PMC1490914 (PubMed Central)